Free Access
Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukaemia
Parameswaran Anoop, Andy Wotherspoon,
Estella Matutes,
Andy Wotherspoon
Histopathology, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, London, UK.E-mail: [email protected]
Search for more papers by this authorParameswaran Anoop, Andy Wotherspoon,
Estella Matutes,
Andy Wotherspoon
Histopathology, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, London, UK.E-mail: [email protected]
Search for more papers by this author
References
- Besson, C., Canioni, D., Lepage, E., Pol, S., Morel, P., Lederlin, P., Van Hoof, A., Tilly, H., Gaulard, P., Coiffier, B., Gisselbrecht, C., Brousse, N., Reyes, F. & Hermine, O.; Groupe d’Etude des Lymphomes de l’Adulte Programs (2006) Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98. Journal of Clinical Oncology, 24, 953–960.
- Ennishi, D., Yokoyama, M., Terui, Y., Takeuchi, K., Ikeda, K., Tanimoto, M. & Hatake, K. (2008a) Does rituximab really induce hepatitis C virus reactivation? Journal of Clinical Oncology, 26, 4695–4696.
- Ennishi, D., Terui, Y., Yokoyama, M., Mishima, Y., Takahashi, S., Takeuchi, K., Okamoto, H., Tanimoto, M. & Hatake, K. (2008b) Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy. American Journal of Hematology, 83, 59–62.
- Hallek, M., Cheson, B.D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M.J., Montserrat, E., Rai, K.R. & Kipps, T.J. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute Working Group 1996 guidelines. Blood, 111, 5446–5456.
- Hsieh, C.Y., Huang, H.H., Lin, C.Y., Chung, L.W., Liao, Y.M., Bai, L.Y. & Chiu, C.F. (2008) Rituximab induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma. Journal of Clinical Oncology, 26, 2584–2586.
- Melisko, M.E., Fox, R. & Venook, A. (2004) Reactivation of hepatitis C virus after chemotherapy for colon cancer. Clinical Oncology (Royal College of Radiologists (Great Britain)), 16, 204–205.
- Milligan, D.W., Fernandes, S., Dasgupta, R., Davies, F.E., Matutes, E., Fegan, C.D., McConkey, C., Child, J.A., Cunningham, D., Morgan, G.J. & Catovsky, D. (2005) Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses. Blood, 105, 397–404.
- Rommel, F., Toepfer, M., Eberle, J., Schiffl, H., Spannagl, M. & Schramm, W. (2000) Reactivation of chronic hepatitis C virus infection by immunoadsorption in factor VIII inhibitor haemophilia. Thrombosis and Haemostasis, 84, 733–734.
-
Zuckerman, E.,
Zuckerman, T.,
Douer, D.,
Qian, D. &
Levine, A.M. (1998) Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
Cancer, 83, 1224–1230.
10.1002/(SICI)1097-0142(19980915)83:6<1224::AID-CNCR23>3.0.CO;2-6 CAS PubMed Web of Science® Google Scholar
Citing Literature
